Delivery Order SPE2DB20D1004-SPE2DB23FG2M8

Award Date 7/19/23
Potential Completion Date 7/20/23
Potential Value $10K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of RYTARY ER 36.25 MG-145 MG CAP 100S pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $1,723.26, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price, and the ultimate completion date is December 4, 2023. The contract is not set aside for any specific type of business. Amerisourcebergen...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,067.18 for the pharmaceutical product RYTARY ER 36.25 MG-145 MG CAP 100S. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, and has an ultimate completion date of April 29, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,248.50 firm fixed-price delivery order contract is for the provision of RYTARY ER 48.75 MG-195 MG CAP 100S, a specialty pharmaceutical product. The contract has an ultimate completion date of May 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
The federal contract award is for the delivery of RYTARY ER 36.25 MG-145 MG CAP 100S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $15,796.42 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of September 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999,...
This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,482.63, is a Firm Fixed Price Delivery Order to provide RYTARY ER 48.75 MG-195 MG CAP 100S to the government. The contract has a completion date of February 20, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of RYTARY ER 36.25 MG-145 MG CAP 100S pharmaceutical products. The contract, valued at $2,991.98, was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 30, 2024. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,691.17 firm fixed-price delivery order is for RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,424.28 for the pharmaceutical product RYTARY ER 23.75 MG-95 MG CAP 100S. The contract was awarded on August 7, 2023, with an ultimate completion date of August 8, 2023, and was issued by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of RYTARY ER 48.75 MG-195 MG capsules. The Firm Fixed Price delivery order, valued at $4,046.18, has a performance period ending on March 31, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This...
The U.S. Defense Logistics Agency (DLA) awarded a $1,272.84 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide RYTARY ER 36.25 MG-145 MG capsules. This contract has an ultimate completion date of May 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FG2M8
    Delivery Order

This federal contract award is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S pharmaceutical product to the Defense Logistics Agency (DLA). The contract, valued at $10,448.56, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a completion date of July 20, 2023 and is a firm fixed-price delivery order. There is no set-aside designation for this award.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:46 AM